DK3234159T3 - Rekombinant svinekoppervirus og vacciner - Google Patents
Rekombinant svinekoppervirus og vacciner Download PDFInfo
- Publication number
- DK3234159T3 DK3234159T3 DK15813838.8T DK15813838T DK3234159T3 DK 3234159 T3 DK3234159 T3 DK 3234159T3 DK 15813838 T DK15813838 T DK 15813838T DK 3234159 T3 DK3234159 T3 DK 3234159T3
- Authority
- DK
- Denmark
- Prior art keywords
- vaccines
- virus
- recombinant pig
- pig copper
- copper
- Prior art date
Links
- 241000700605 Viruses Species 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24041—Use of virus, viral particle or viral elements as a vector
- C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24071—Demonstrated in vivo effect
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
- C12N2750/00011—Details
- C12N2750/10011—Circoviridae
- C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP14307110.8A EP3034609A1 (en) | 2014-12-19 | 2014-12-19 | Recombinant swinepox virus and vaccines |
| PCT/EP2015/080468 WO2016097281A1 (en) | 2014-12-19 | 2015-12-18 | Recombinant swinepox virus and vaccines |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3234159T3 true DK3234159T3 (da) | 2019-09-23 |
Family
ID=52345012
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK15813838.8T DK3234159T3 (da) | 2014-12-19 | 2015-12-18 | Rekombinant svinekoppervirus og vacciner |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US10106819B2 (da) |
| EP (2) | EP3034609A1 (da) |
| CN (1) | CN107532151B (da) |
| CA (1) | CA2969605C (da) |
| DK (1) | DK3234159T3 (da) |
| ES (1) | ES2748468T3 (da) |
| MX (1) | MX2017008087A (da) |
| PH (1) | PH12017501100A1 (da) |
| RU (1) | RU2727899C2 (da) |
| WO (1) | WO2016097281A1 (da) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3254692A1 (en) | 2016-06-10 | 2017-12-13 | Ceva Sante Animale | Multivalent recombinant spv |
| WO2019110820A1 (en) * | 2017-12-08 | 2019-06-13 | Ceva Sante Animale | Recombinant swinepox virus encoding a pcv3 antigen |
| US20200390878A1 (en) | 2017-12-08 | 2020-12-17 | Ceva Sante Animale | Recombinant swinepox virus and vaccines |
| CN113373119A (zh) * | 2021-06-02 | 2021-09-10 | 江西农业大学 | 一种表达非洲猪瘟病毒三基因缺失重组伪狂犬病毒毒株、构建方法及其应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2531729B2 (ja) | 1987-03-27 | 1996-09-04 | 日本ゼオン株式会社 | 組み換えアビポックスウイルス |
| US5651972A (en) | 1989-04-21 | 1997-07-29 | University Of Florida Research Foundation, Inc. | Use of recombinant swine poxvirus as a live vaccine vector |
| US6127163A (en) * | 1992-01-13 | 2000-10-03 | Syntro Corporation | Recombinant swinepox virus |
| RU2076735C1 (ru) * | 1994-03-23 | 1997-04-10 | ГНЦВБ "Вектор" | Живая рекомбинантная вакцина гепатита в на основе вируса осповакцины для перорального применения и способ ее получения |
| UA78180C2 (uk) | 1997-10-03 | 2007-03-15 | Меріаль | Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти |
| FR2772047B1 (fr) | 1997-12-05 | 2004-04-09 | Ct Nat D Etudes Veterinaires E | Sequence genomique et polypeptides de circovirus associe a la maladie de l'amaigrissement du porcelet (map), applications au diagnostic et a la prevention et/ou au traitement de l'infection |
| EP1816200B1 (en) | 1997-12-11 | 2016-03-09 | Merial | Postweaning multisystemic wasting syndrome virus for pigs |
| EP2225367A1 (en) | 2007-12-21 | 2010-09-08 | Wyeth LLC | Methods and compositions for immunizing pigs against porcine circovirus |
| EP2367933A1 (en) | 2008-11-28 | 2011-09-28 | Ceva Sante Animale | Novel porcine circovirus type 2b isolate and uses thereof |
| EP2564869A1 (en) | 2011-09-02 | 2013-03-06 | Ceva Sante Animale | Synthetic capsid proteins and uses thereof |
| EP2789346A1 (en) | 2013-04-11 | 2014-10-15 | CEVA Santé Animale SA | Fusion polypeptides and vaccines |
-
2014
- 2014-12-19 EP EP14307110.8A patent/EP3034609A1/en not_active Withdrawn
-
2015
- 2015-12-18 RU RU2017125494A patent/RU2727899C2/ru active
- 2015-12-18 WO PCT/EP2015/080468 patent/WO2016097281A1/en active Application Filing
- 2015-12-18 EP EP15813838.8A patent/EP3234159B1/en active Active
- 2015-12-18 MX MX2017008087A patent/MX2017008087A/es active IP Right Grant
- 2015-12-18 US US15/536,058 patent/US10106819B2/en active Active
- 2015-12-18 CN CN201580076539.8A patent/CN107532151B/zh active Active
- 2015-12-18 ES ES15813838T patent/ES2748468T3/es active Active
- 2015-12-18 DK DK15813838.8T patent/DK3234159T3/da active
- 2015-12-18 CA CA2969605A patent/CA2969605C/en active Active
-
2017
- 2017-06-13 PH PH12017501100A patent/PH12017501100A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20170335343A1 (en) | 2017-11-23 |
| RU2017125494A3 (da) | 2019-07-17 |
| ES2748468T3 (es) | 2020-03-16 |
| WO2016097281A1 (en) | 2016-06-23 |
| CA2969605A1 (en) | 2016-06-23 |
| RU2017125494A (ru) | 2019-01-21 |
| CN107532151B (zh) | 2021-10-19 |
| MX2017008087A (es) | 2017-10-31 |
| EP3234159B1 (en) | 2019-06-12 |
| US10106819B2 (en) | 2018-10-23 |
| PH12017501100B1 (en) | 2017-11-27 |
| CN107532151A (zh) | 2018-01-02 |
| BR112017012998A2 (pt) | 2018-03-06 |
| EP3034609A1 (en) | 2016-06-22 |
| CA2969605C (en) | 2023-06-20 |
| PH12017501100A1 (en) | 2017-11-27 |
| RU2727899C2 (ru) | 2020-07-24 |
| EP3234159A1 (en) | 2017-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3872085T3 (da) | Stam-virussekvenser og anvendelser heraf | |
| DK3393505T3 (da) | Rekombinante zika-vacciner | |
| DK3471755T3 (da) | Pegyleret svineinterferon og fremgangsmåder til anvendelse deraf | |
| ZA201701851B (en) | Fmdv recombinant vaccines and uses thereof | |
| DK3212255T3 (da) | Selvorienterende sprøjte og sprøjtegrænseflade | |
| DK3247722T3 (da) | Cytomegalovirusantigener og anvendelser deraf | |
| DK3268470T3 (da) | Transposasepolypeptider og anvendelser deraf | |
| DK3412302T3 (da) | Modificerede fgf-21-polypeptider og anvendelser deraf | |
| IL286265A (en) | A new tilapia virus and its uses | |
| DK3212189T3 (da) | Substituerede chromaner og fremgangsmåde til anvendelse deraf | |
| DK3480213T3 (da) | Syntac-polypeptider og anvendelser deraf | |
| DK3333191T3 (da) | Anti-C10ORF54-antistoffer og anvendelser deraf | |
| DK3313882T3 (da) | Anti-VISTA antistoffer og fragmenter | |
| DK3126388T3 (da) | Anti-EGFRvIII-antistoffer og anvendelser deraf | |
| DK3218358T3 (da) | Ifluorometyl-aminopyridiner og difluorometyl-aminopyrimidiner | |
| DK3193611T3 (da) | Mk2-inhibitorer og anvendelser deraf | |
| DK3101760T3 (da) | Opladningsfremgangsmåde og system | |
| DK3346056T3 (da) | Rengøringssystem og fremgangsmåde | |
| DK3265641T3 (da) | Stigørenhed og fremgangsmåde | |
| DK3161139T3 (da) | Tlr-4-specifikke aptamerer og anvendelser heraf | |
| DK3209773T3 (da) | Prolintolerante tripeptidylpeptidaser og anvendelser deraf | |
| DK3123071T3 (da) | Koblingsenhed og tilhørende fremgangsmåde | |
| DK3206733T3 (da) | Leveringssystem og driftsmodus | |
| DK3113795T3 (da) | Rekombinante virale isfahan-vektorer | |
| IL287985A (en) | A peptide derived from koc1 and a component containing it |